Tilmicosin

DB11471InvestigationalVet approvedSmall molecule

Tilmicosin is a macrolide antibiotic. It is used in veterinary medicine for the treatment of bovine respiratory disease and ovine respiratory disease associated with Mannheimia haemolytica.

Formula / weight: C₄₆H₈₀N₂O₁₃ · 869.147 g/mol (avg)
Code names: EL-870 · LY-177370

Resolves to

Compound

UNIIXL4103X2E3CAS108050-54-0ChEMBLCHEMBL1908333KEGGD02492

Clinical / RWD

RxNorm38278

Structure

InChIKeyJTSDBFGMPLKDCD-XVFHVFLVSA-NSMILES

CC[C@H]1OC(=O)C[C@@H](O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@@H]([C@H]2O)N(C)C)[C@@H](CCN2C[C@@H](C)C[C@@H](C)C2)C[C@@H](C)C(=O)\C=C\C(\C)=C\[C@@H]1CO[C@@H]1O[C@H](C)[C@@H](O)[C@@H](OC)[C@H]1OC

Transporters

P08183ABCB1Q9UNQ0ABCG2

What you can answer from here — as of August 30, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2TransportersSubstrate / inhibitor direction, not just membership

Listed above

174Drug interactionsStructured to mechanism, not free text

46Marketed productsAcross 1 country and 23 labellers

16+ReferencesStructured and connected to the statements they support

Which companies are running trials of Tilmicosin, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account